Delivery Order SPE2DR25D1100-SPE2DR26FDC2W
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,806.98 to AmerisourceBergen Drug Corp for 28 units of Afinitor 10 mg tablets in unit-dose packaging. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 2, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The place of performance...
- The Defense Logistics Agency awarded a $13,806.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Afinitor 10 mg tablets (28-unit dose packages) with an ultimate completion date of January 26, 2026. This non-set-aside contract was competitively awarded on January 2, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Afinitor 10 mg tablets in unit dose packages of 28 count. This competitively awarded, firm fixed-price contract carries a ceiling value of $12,360.81 and is scheduled for completion by September 2, 2025. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. As a delivery order,...
- The Defense Logistics Agency awarded a delivery order valued at $13,017.66 to AmerisourceBergen Drug Corp for Afinitor 5 mg tablets (28-count unit dose packaging) on November 7, 2025, with completion scheduled for December 2, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award falls under the company's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $24,721.64 to AmerisourceBergen Drug Corp for the supply of Afinitor 10 mg tablet unit dose packages (28-count) on April 24, 2025, with an ultimate completion date of May 15, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 28 units of Afinitor 5 mg tablets in unit dose packaging, valued at $37,057.56 under a firm fixed price contract type. The award, issued on October 27, 2025, is scheduled for completion by November 18, 2025, with performance taking place at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. This is a competitively awarded non-set-aside contract, reflecting the company's established capability to...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Afinitor 5 mg tablets in unit dose packaging (28-count), with a contract ceiling value of $38,092.75 and a firm fixed-price structure. This delivery order, designated as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with the Defense Logistics Agency Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $13,026.39 to AmerisourceBergen Drug Corp for Afinitor 10 mg tablets (28-count unit dose packaging) on December 31, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of January 23, 2026. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a $12,352.52 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AFINITOR 5 MG TABLET UD 28S, a prescription medication, with a period of performance through June 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Afinitor Disperz 3 mg tablets in quantities of 28 count, with a ceiling value of $47,663.84 and an ultimate completion date of June 23, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with the Defense Logistics...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FDC2WDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,613.96 to Amerisourcebergen Drug Corp for the supply of Afinitor 10 mg tablets in unit dose packaging (28-count). This competitively awarded, firm fixed-price contract was issued on January 28, 2026, with a completion date of February 19, 2026. The work will be performed at Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. (formerly known as Amerisourcebergen), a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems. This delivery order is issued under Cencora's larger Indefinite Delivery Contract with the DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 and extending through December 2031. The IDC enables the company to supply an extensive range of pharmaceutical products, brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs worldwide, including services to the Defense Health Agency and U.S. Coast Guard. Afinitor (everolimus) is a targeted cancer therapy used in military and veteran healthcare systems, and this delivery order fulfills immediate procurement needs within the larger contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.6k | 1/27/26 |